US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

NovaBridge Biosciences

3.22

+0.01000.31%

Post-market: 3.300.0800+2.48%19:11 EST

Volume:312.69K

Turnover:996.75K

Market Cap:371.16M

PE:-10.67

High:3.31

Open:3.30

Low:3.05

Close:3.21

52wk High:6.79

52wk Low:0.5950

Shares:115.27M

Float Shares:48.23M

Volume Ratio:1.06

T/O Rate:0.65%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3017

EPS(LYR):-0.2738

ROE:-18.46%

ROA:-10.36%

PB:1.43

PE(LYR):-11.76

Loading ...

Overview Company News Filings

NovaBridge enrolls first patient in givastomig combination study

NovaBridge Biosciences Launches Phase 2 Trial of Givastomig in Metastatic Gastric Cancer

Novabridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined With Immunochemotherapy in Patients With 1L Metastatic Gastric Cancer

THOMSON REUTERS

Novabridge Biosciences - Top Line Phase 2 Results Expected in 2027

THOMSON REUTERS

Top Wall Street Analysts' Latest Ratings: Amazon Downgraded, Roblox Upgraded

NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy

NovaBridge Biosciences Is Maintained at Buy by HC Wainwright & Co.

NovaBridge resumed with a Buy at H.C. Wainwright

Novabridge Biosciences : H.c. Wainwright Raises Target Price to $9 From $7

THOMSON REUTERS

NovaBridge Biosciences Shares Rise After Chairman Pledges to Buy Shares

NovaBridge announces open market purchases by executive chairman Fu Wei

Novabridge Announces Open Market Purchases by Executive Chairman, Fu Wei

THOMSON REUTERS

NovaBridge Biosciences Executive Chairman Begins Up to $5 Million Open-Market ADS Purchase

BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla

What's Going On With NovaBridge Stock Tuesday?

BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin

BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge

Novabridge Biosciences Shares Climb 6.9% Premarket After Cancer Drug Shows Promise in Early Trial

THOMSON REUTERS

BUZZ-NovaBridge rises as cancer drug shows promise in early trial

NovaBridge Biosciences Reports Positive Phase 1b Results for Givastomig in Metastatic Gastric Cancer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/NBP/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","market":"US","secType":"STK","nameCN":"NovaBridge Biosciences","latestPrice":3.22,"timestamp":1771362000000,"preClose":3.21,"halted":0,"volume":312692,"hourTrading":{"tag":"盘后","latestPrice":3.3,"preClose":3.22,"latestTime":"19:11 EST","volume":4175,"amount":13651.315,"timestamp":1771373507293,"change":0.08,"changeRate":0.024845,"amplitude":0.073696},"delay":0,"changeRate":0.00311526479750786,"floatShares":48234000,"shares":115266053,"eps":-0.30172,"marketStatus":"Not Yet Opened","change":0.01,"latestTime":"02-17 16:00:00 EST","open":3.3,"high":3.31,"low":3.0513,"amount":996749.7457644001,"amplitude":0.080592,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.30172,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771405200000},"marketStatusCode":0,"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":3.21,"preHourTrading":{"tag":"盘前","latestPrice":3.32,"preClose":3.21,"latestTime":"09:29 EST","volume":116,"amount":383.0500148,"timestamp":1771338560155,"change":0.11,"changeRate":0.034268,"amplitude":0.037383},"postHourTrading":{"tag":"盘后","latestPrice":3.3,"preClose":3.22,"latestTime":"19:11 EST","volume":4175,"amount":13651.315,"timestamp":1771373507293,"change":0.08,"changeRate":0.024845,"amplitude":0.073696},"volumeRatio":1.055994,"impliedVol":2.8391,"impliedVolPercentile":0.8378},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NBP\",,,,,undefined,":{"symbol":"NBP","floatShares":48234000,"roa":"-10.36%","roe":"-18.46%","lyrEps":-0.273814,"volumeRatio":1.055994,"shares":115266053,"dividePrice":0,"high":3.31,"amplitude":0.080592,"preClose":3.21,"low":3.0513,"week52Low":0.595,"pbRate":"1.43","week52High":6.79,"institutionHeld":0,"latestPrice":3.22,"eps":-0.30172,"divideRate":0,"volume":312692,"delay":0,"ttmEps":-0.30172,"open":3.3,"prevYearClose":3.98,"prevWeekClose":3.21,"prevMonthClose":3.31,"prevQuarterClose":3.98,"fiveDayClose":3.47,"twentyDayClose":3.73,"sixtyDayClose":4.54},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-20","symbol":"NBP","fiscalQuarterEnding":"2025/06","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"pre","actualEps":-0.07},{"market":"US","date":"2025-05-15","symbol":"NBP","fiscalQuarterEnding":"2025/03","expectedEps":-0.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":-0.04},{"market":"US","date":"2025-04-03","symbol":"NBP","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743652800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-14","symbol":"NBP","fiscalQuarterEnding":"2024/09","expectedEps":-0.16,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.25},{"market":"US","date":"2024-08-28","symbol":"NBP","fiscalQuarterEnding":"2024/06","expectedEps":-0.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1724817600000,"reportTimeType":"pre","actualEps":-0.07}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NBP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4,"buy":0.6,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6,"analysts":5,"updateTime":1759726800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NBP","date":"2026-02-13","current":-10.672146,"percent":0.549296,"low":-20.276437,"twenty":-17.307231,"median":-14.71465,"eighty":-11.823489,"high":-10.607129,"avg":-14.602704,"sd":2.704988,"marketCap":373542940},"quantilePoints":[{"date":"2025-10-31","current":-13.114792,"twenty":-13.114792,"median":-13.114792,"eighty":-13.114792,"marketCap":524460541},{"date":"2025-11-07","current":-12.077138,"twenty":-13.547148,"median":-12.71126,"eighty":-12.278904,"marketCap":482964762},{"date":"2025-11-14","current":-12.019491,"twenty":-13.114792,"median":-12.278904,"eighty":-12.077138,"marketCap":480659441},{"date":"2025-11-21","current":-12.077138,"twenty":-13.085968,"median":-12.293316,"eighty":-12.077138,"marketCap":482964762},{"date":"2025-11-28","current":-11.068308,"twenty":-13.06291,"median":-12.192433,"eighty":-11.881137,"marketCap":442621643},{"date":"2025-12-05","current":-11.500664,"twenty":-12.688201,"median":-12.077138,"eighty":-11.212426,"marketCap":459911551},{"date":"2025-12-12","current":-11.298898,"twenty":-12.411494,"median":-12.033903,"eighty":-11.287368,"marketCap":451842927},{"date":"2025-12-19","current":-17.342266,"twenty":-12.688201,"median":-12.048315,"eighty":-11.460311,"marketCap":456552482},{"date":"2025-12-26","current":-20.276437,"twenty":-13.287734,"median":-12.077138,"eighty":-11.500664,"marketCap":533797473},{"date":"2026-01-02","current":-17.429853,"twenty":-17.342266,"median":-12.163609,"eighty":-11.512194,"marketCap":458858303},{"date":"2026-01-09","current":-16.597774,"twenty":-17.482405,"median":-12.235668,"eighty":-11.541017,"marketCap":436953007},{"date":"2026-01-16","current":-16.028458,"twenty":-17.394818,"median":-12.365376,"eighty":-11.569841,"marketCap":421965173},{"date":"2026-01-23","current":-17.03571,"twenty":-17.342266,"median":-13.057145,"eighty":-11.587135,"marketCap":448482110},{"date":"2026-01-30","current":-16.116045,"twenty":-17.3773,"median":-13.33097,"eighty":-11.615959,"marketCap":424270994},{"date":"2026-02-06","current":-14.583269,"twenty":-17.342266,"median":-14.495682,"eighty":-11.742783,"marketCap":383919133},{"date":"2026-02-13","current":-14.189126,"twenty":-17.307231,"median":-14.71465,"eighty":-11.823489,"marketCap":373542940}],"updateTime":1771370045718},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NBP\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612493099","title":"NovaBridge enrolls first patient in givastomig combination study","url":"https://stock-news.laohu8.com/highlight/detail?id=2612493099","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612493099?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:45","pubTimestamp":1771364716,"startTime":"0","endTime":"0","summary":"NovaBridge (NBP) announced enrollment of the first patient in the global Phase 2 randomized combination study evaluating givastomig, a Claudin 18.2...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novabridge-enrolls-first-patient-in-givastomig-combination-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novabridge-enrolls-first-patient-in-givastomig-combination-study-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2612460932","title":"NovaBridge Biosciences Launches Phase 2 Trial of Givastomig in Metastatic Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460932","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460932?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:08","pubTimestamp":1771362498,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences has announced the initiation of a global, randomized Phase 2 clinical study evaluating givastomig, a Claudin 18.2 x 4-1BB bispecific antibody, in combination with nivolumab and chemotherapy  in patients with first-line  metastatic HER2-negative gastric cancer. The Phase 2 trial follows positive Phase 1b results, which demonstrated a 75% objective response rate and a median progression-free survival of 16.9 months. Top line results from the Phase 2 study are expected in 2027, and updated results from the Phase 1b dose expansion study are anticipated in the second half of this year.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NovaBridge Biosciences published the original content used to generate this news brief ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nNDL30yMMd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2612460327","title":"Novabridge Doses First Patient in Global, Randomized Phase 2 Study of Givastomig Combined With Immunochemotherapy in Patients With 1L Metastatic Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2612460327","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612460327?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUATRGKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2612066498","title":"Novabridge Biosciences - Top Line Phase 2 Results Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2612066498","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612066498?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:05","pubTimestamp":1771362302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nTUATRGKK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"1179564662","title":"Top Wall Street Analysts' Latest Ratings: Amazon Downgraded, Roblox Upgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=1179564662","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179564662?lang=en_us&edition=fundamental","pubTime":"2026-02-07 00:54","pubTimestamp":1770396881,"startTime":"0","endTime":"0","summary":"A summary of the most watched and market-moving analyst rating changes from Wall Street is provided below. The following institutional rating adjustments, compiled by The Fly, require investors'...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE00BK4W5L77.USD","BOOT","LU0251132253.USD","LU0965509101.SGD","LU0029864427.USD","LU2089284900.SGD","LU2471134952.CNY","LU2242649171.HKD","LU2083900584.USD","LU0345770308.USD","LU1791710582.SGD","LU1066053197.SGD","IE00BK4W5M84.HKD","LU1989764748.USD","LU2430703178.SGD","LU0342679015.USD","LU0097036916.USD","LU1232071149.USD","LU0323591593.USD","PI","LU2065169927.USD","BK4579","LU2505996509.AUD","LU1548497426.USD","BK4532","GB00BDT5M118.USD","IE0001KFT4U8.USD","LU0787776722.HKD","LU2065171402.SGD","LU1366333091.USD","LU2168563687.JPY","LU1868837300.USD","SG9999017495.SGD","LU2552382132.HKD","LU2023250504.SGD","LU0265550359.USD","LU1914381329.SGD","LU2456880835.USD","LU1674673691.USD","BK4524","IE0009G5SDU7.USD","LU0289941410.SGD","LU0640476718.USD","BK4585","LU2764263039.SGD","LU2430703095.HKD","BK4566","LU1551013425.SGD","IE00B5949003.HKD","LU1066051225.USD","SG9999014880.SGD","LU2505996681.GBP","IE00B7SZLL34.SGD","LU1935042991.SGD","SG9999004303.SGD","IE000ITXATA3.USD","IE00B19Z3581.USD","AMZY","BK4543","LU0965509010.AUD","LU2764262908.HKD","LU0494093205.USD","LU0130102774.USD","IE00BFSS8Q28.SGD","LU0053666078.USD","LU0345768740.USD","LU2592432038.USD","LU1145028129.USD","LU0985320562.USD","IE00BJJMRX11.SGD","SG9999000418.SGD","LU0203201768.USD","LU0719512351.SGD","IE00BQXX3D17.EUR","LU0882574139.USD","IE0004445015.USD","LU0149725797.USD","LU1127390331.HKD","LU0208291251.USD","LU0820562030.AUD","IE000YTNTUN2.SGD","LU0353189680.USD","AMZU","LU1064131342.USD","LU1116320737.USD","IE0004445239.USD","LU2471134796.USD","LU2237438978.USD","LU1066051811.HKD","LU0170899867.USD","LU0310799852.SGD","IE00B5TLWC47.USD","LU0889565833.HKD","LU2065171311.SGD","LU1868837136.USD","LU2211817866.USD","JBS","LU1069344957.HKD","LU0312595415.SGD","LU2237957811.SGD","LU0823434740.USD","HK0000914686.HKD","LU1046421795.USD","LU0211328371.USD","LU0320765059.SGD","LU2213496289.HKD","LU2417539215.USD","LU0788109477.HKD","LU2092627202.USD","LU2264538146.SGD","LU0215105999.USD","LU1861559042.SGD","LU1323610961.USD","LU0096362180.USD","LU0302445910.USD","LU0689472784.USD","LU0980610538.SGD","LU2065170008.USD","LU0234572021.USD","LU2271345857.HKD","LU0162691827.USD","LU1037948541.HKD","LU0724617625.USD","LU1804176565.USD","LU1839511570.USD","LU0964807845.USD","LU1934455863.HKD","IE00BJLML261.HKD","LU2462157665.USD","IE00BJJMRY28.SGD","MMSI","LU1201861249.SGD","LU1035775433.USD","NBP","LU0823434583.USD","SG9999001077.SGD","BK4596","LU1720051108.HKD","LU1861558580.USD","IE00B19Z3B42.SGD","LU0265550946.USD","SGXZ23171101.USD","BK4535","LU0127658192.USD","IE00B7KXQ091.USD","LU2360032135.SGD","IE0034235303.USD","LU2111349929.HKD","SG9999015945.SGD","HK0000914660.USD","IE00BQXX3C00.GBP","LU0345768153.USD","LU2750360641.GBP","LU1934455277.USD","BK4612","LU2077746001.SGD","USAW.SI","LU1267930490.SGD","LU2125154935.USD","IE00BKDWB100.SGD","LU2168564495.EUR","LU2361044865.SGD","LU2860962120.EUR","IE0009356076.USD","BK4598","LU0267386448.USD","LU0320765489.SGD","LU0957791311.USD","LU2420271590.USD","LU1633808545.USD","LU0079474960.USD","LU0072461881.USD","SG9999015986.USD","BK4592","HUBG","IE00B1BXHZ80.USD","BK4507","BK4565","LU2746668461.USD","LU2764263203.CNY","IE00BWXC8680.SGD","SGXZ31699556.SGD","LU0109392836.USD","IE00BYQQ9H92.USD","LU2250418816.HKD","LU2756315664.SGD","LU1791710400.SGD","BK4559","LU1691799644.USD","BK4527","LU2125154778.USD","SG9999015952.SGD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1244550221.USD","LU0056508442.USD","LU1861127337.USD","LU0077335932.USD","LU2360106780.USD","LU2326559502.SGD","IE00BJTD4N35.SGD","IE0005OL40V9.USD","BK4534","LU2054465674.USD","LU1935042488.USD","LU0314104364.USD","SGXZ99366536.SGD","LU0642271901.SGD","LU0354030438.USD","BK4604","LU1814569148.SGD","LU2362541273.HKD","LU0210536198.USD","BK4561","LU2463028550.USD","SRE","BK4538","LU0353189763.USD","LU2087625088.SGD","LU1880398554.USD","LU2168564149.EUR","LU1974910355.USD","BK4548","SG9999018857.SGD","LU0238689110.USD","BK4122","JMIA","IE00BFSS7M15.SGD","IE00BJTD4V19.USD","LU0256863902.USD","IE00BKVL7J92.USD","LU1935043536.SGD","SG9999002232.USD","LU0175139822.USD","BK4085","IE00B19Z8W00.USD","IE00B1XK9C88.USD","IE00BMPRXN33.USD","LU0011850046.USD","LU2211815571.USD","IE0002270589.USD","LU2602419157.SGD","LU2023250330.USD","IE00B4JS1V06.HKD","LU2403377893.USD","LU0072462426.USD","LU1934455194.USD","LU2247934214.USD","LU0943347566.SGD","LU0070302665.USD","LU0310800379.SGD","LU1267930573.SGD","LU2487616109.SGD","LU1037948897.HKD","LU0158827948.USD","LU0965509283.SGD","LU2092937148.SGD","LU2471134523.USD","LU0390134368.USD","IE00BFXG0V08.USD","LU0648000940.SGD","LU1868836914.USD","LU1880398471.USD","IE00B3S45H60.SGD","LU2028103732.USD","LU1244550577.SGD","LU0456855351.SGD","LU0345770993.USD","LU2461242641.AUD","LU0061474960.USD","LU2089283258.USD","AMZZ","LIN","LU0528227936.USD","LU0466842654.USD","LU0061475181.USD","LU0820561909.HKD","SGXZ81514606.USD","LU2552382058.USD","LU1316542783.SGD","LU2756315318.SGD","LU0289960550.SGD","LU0130103400.USD","LU0158827781.USD","LU2381873111.SGD","LU1551013342.USD","LU2896262040.SGD","LU0345774631.USD","LU0096364046.USD","BK4581","LU0082616367.USD","LU2236285917.USD","LU1280957306.USD","IE0003U64NQ7.SGD","IE0004091025.USD","EL","LU1496350502.SGD","LU0345769128.USD","SG9999014906.USD","LU0354030511.USD","LU1935042215.USD","BK4554","LU1868836591.USD","LU0234570918.USD","BK4547","LU1852331112.SGD","LU0348723411.USD","LU0823421333.USD","IE00BN29S564.USD","LU2362541513.USD","IE00B4YYXB79.USD","LU1119994496.HKD","LU0672654240.SGD","LU2265009873.SGD","LU0154236417.USD","LU0210528500.USD","LU0048584097.USD","IE00B775SV38.USD","IE00B775H168.HKD","LU2361045086.USD","LU1823568750.SGD","LU2106854487.HKD","LU1066051498.USD","SG9999014898.SGD","LU1718418525.SGD","LU2063271972.USD","LU2362540622.SGD","LU0210533765.USD","AMZW","LU1989764664.SGD","LU1235294995.USD","SNAP","RBLX","AMZN","LU2275660780.HKD","IE00BQXX3F31.USD","LU0683600562.USD","AMZD","LU0345769631.USD","LU0417517546.SGD","LU1720051017.SGD","LU2237957902.USD","LU2023251221.USD","LU0157215616.USD","BK4588","LU0308772762.SGD","LU1116320901.HKD","LU2750360997.AUD","LU1435385759.SGD","LU2361044949.HKD","LU0648001328.SGD","LU1201861165.SGD","LU1917777945.USD","LU2552382215.SGD","LU2087621335.USD","LU0061474705.USD","SG9999018865.SGD","LU1261432733.SGD","BK4533","LU1629891620.HKD","LU2357305700.SGD","LU0128525929.USD","LU2430703251.USD","LU0107464264.USD","LU2097829019.USD","LU2168564222.USD","LU1496350171.SGD","LU0708994859.HKD","LU0345774391.USD","LU0820561818.USD","LU1868836757.USD","AZYY","LU0080751232.USD","LU1366192091.USD","LU2471134879.HKD","IE00BMPRXR70.SGD","LU1935043023.USD","SG9999014914.USD","LU1815333072.USD","LU1429558221.USD","LU1988902786.USD","SGXZ51526630.SGD","LU2108987350.USD","LU1244550494.USD","LU0965508806.USD","LU1267930730.SGD","LU1084165304.USD","IE00B3SWFQ91.USD","IE00B19Z8X17.USD","LU1883839398.USD","LU2543165471.USD","LU0708995401.HKD","LU1674673428.USD","LU0070217475.USD","LU2746668974.SGD","LU0256863811.USD","LU0786609619.USD","IE00BKPKM429.USD","LU1074936037.SGD","LU2317271919.USD","BK4550","IE00B19Z9505.USD","LU1153585028.USD","LU0823421416.USD","IE000KEQY171.SGD","LU2242650005.HKD","LU0198837287.USD","LU1803068979.SGD","IE000W1ABFV2.USD","BK4220","LU2168564065.EUR","LU0203202063.USD","LU0109391861.USD","ROKU","LU2720916845.USD","LU0276348264.USD","BK4503","LU1778281490.HKD","BK4551","SIRI","LU0316494557.USD","IE0004086264.USD","SG9999002224.SGD","LU2452424414.USD","IE00BMPRXQ63.HKD","LU0823411888.USD","LU0211327993.USD"],"gpt_icon":1},{"id":"2609859186","title":"NovaBridge Biosciences Unveils February 2026 Investor Presentation Highlighting Global Hub-and-Spoke Biotech Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2609859186","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609859186?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:59","pubTimestamp":1770386359,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences ( ($NBP) ) just unveiled an announcement. On February 6, 2026, NovaBridge Biosciences furnished an updated investor presenta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-unveils-february-2026-investor-presentation-highlighting-global-hub-and-spoke-biotech-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-unveils-february-2026-investor-presentation-highlighting-global-hub-and-spoke-biotech-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBP","HUBG","IE00B66KJ199.SGD","IE0031619046.USD","LABU","BK4585","BK4588","BK4131","IE00B19Z4B17.USD","BK4139","IE00B7SZL793.SGD"],"gpt_icon":0},{"id":"2609593917","title":"NovaBridge Biosciences Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2609593917","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609593917?lang=en_us&edition=fundamental","pubTime":"2026-02-06 20:37","pubTimestamp":1770381420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/NBP/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 06, 2026 07:37 ET (12:37 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP"],"gpt_icon":0},{"id":"2609562046","title":"NovaBridge resumed with a Buy at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2609562046","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609562046?lang=en_us&edition=fundamental","pubTime":"2026-02-06 19:12","pubTimestamp":1770376333,"startTime":"0","endTime":"0","summary":"H.C. Wainwright resumed coverage of NovaBridge (NBP) with a Buy rating and price target of $9, up from $7. The firm says givastomig has the potenti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novabridge-resumed-with-a-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novabridge-resumed-with-a-buy-at-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2609621975","title":"Novabridge Biosciences : H.c. Wainwright Raises Target Price to $9 From $7","url":"https://stock-news.laohu8.com/highlight/detail?id=2609621975","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609621975?lang=en_us&edition=fundamental","pubTime":"2026-02-06 19:07","pubTimestamp":1770376026,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nAZN4SA9EP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2605481821","title":"NovaBridge Biosciences Shares Rise After Chairman Pledges to Buy Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2605481821","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605481821?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:40","pubTimestamp":1768930800,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences shares were 5.4% higher, at $3.93, after the company said Fu Wei, its executive chairman, intends to buy up to $5 million of the company's American depositary shares in open-market transactions.The biotechnology company said the purchases started Jan. 15, and are ongoing.NovaBridge said that, as the planned purchases are to be executed by Fu Wei via his controlled entity, the company can't guarantee the number of ADSs to be bought or the time frame in which the ADSs will be bought in the open market.NovaBridge shares have more than tripled in the past 12 months.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2604118841","title":"NovaBridge announces open market purchases by executive chairman Fu Wei","url":"https://stock-news.laohu8.com/highlight/detail?id=2604118841","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604118841?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:15","pubTimestamp":1768911328,"startTime":"0","endTime":"0","summary":"NovaBridge (NBP) Biosciences announced that Fu Wei, Executive Chairman of the Board, intends to purchase up to $5,000,000 of the Company’s ADSs in ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novabridge-announces-open-market-purchases-by-executive-chairman-fu-wei-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novabridge-announces-open-market-purchases-by-executive-chairman-fu-wei-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2604419033","title":"Novabridge Announces Open Market Purchases by Executive Chairman, Fu Wei","url":"https://stock-news.laohu8.com/highlight/detail?id=2604419033","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604419033?lang=en_us&edition=fundamental","pubTime":"2026-01-20 20:00","pubTimestamp":1768910406,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA390TQ4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2604911506","title":"NovaBridge Biosciences Executive Chairman Begins Up to $5 Million Open-Market ADS Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2604911506","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604911506?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:27","pubTimestamp":1768598865,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences ( ($NBP) ) just unveiled an announcement. On January 15, 2026, NovaBridge Biosciences’ Executive Chairman Fu Wei began purch...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-executive-chairman-begins-up-to-5-million-open-market-ads-purchase?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/novabridge-biosciences-executive-chairman-begins-up-to-5-million-open-market-ads-purchase?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2601817333","title":"BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2601817333","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601817333?lang=en_us&edition=fundamental","pubTime":"2026-01-07 02:50","pubTimestamp":1767725435,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-United Airlines Holdings, Energy companies, TeslaEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70M5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFC","EXE","LUV","CRNX","REGN","LYFT","NEM","TPG","NTRS","EAT","AEVA","EQIX","COP","ANGO","UAL","ACN","UAA","OS","APGE","PUMP","CFG","STAA","JXN","IFF","SG","CNX","PNC","FGBI","VST","VRTX","BAC","FIX","ALB","BALL","ACRS","AIG","IMSR","WMB","NBP","EPAM"],"gpt_icon":1},{"id":"2601981100","title":"What's Going On With NovaBridge Stock Tuesday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2601981100","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601981100?lang=en_us&edition=fundamental","pubTime":"2026-01-07 01:14","pubTimestamp":1767719640,"startTime":"0","endTime":"0","summary":"NovaBridge stock was trading higher Tuesday but has since reversed and begun trading lower. NovaBridge announced upgrade results from the Phase 1b combination study of givastomig.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/06/Stock-chartbenzingaai2023-stock-market-c.png?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/06/Stock-chartbenzingaai2023-stock-market-c.png?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/trading-ideas/movers/26/01/49731181/whats-going-on-with-novabridge-stock-tuesday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/26/01/49731181/whats-going-on-with-novabridge-stock-tuesday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["NBP","BK4139"],"gpt_icon":0},{"id":"2601819813","title":"BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed Martin","url":"https://stock-news.laohu8.com/highlight/detail?id=2601819813","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601819813?lang=en_us&edition=fundamental","pubTime":"2026-01-06 23:52","pubTimestamp":1767714720,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Shake Shack, Arrowhead Pharmaceuticals, Lockheed MartinEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70VK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRNX","CDE","JXN","GILD","ANGO","STAA","SHAK","HL","FERG","EPAM","MCHP","IFF","BK","ALKS","NBP","OS","CFG","EQIX","APGE","TFC","ZETA","CORZ","ALMS","DLR","O","BAC","REGN","UAA","ACN","ACRS","IMSR","VRTX","GL","AEVA","GNPX","LMT","INTU","STT","AIG","NEM","NTRS","ALB","VST","BALL","PNC"],"gpt_icon":1},{"id":"2601180648","title":"BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridge","url":"https://stock-news.laohu8.com/highlight/detail?id=2601180648","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601180648?lang=en_us&edition=fundamental","pubTime":"2026-01-06 22:12","pubTimestamp":1767708743,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Alkermes, Ball Corp, NovaBridgeEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: ht","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL6N3Y70M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDS.UK","ALKS","ANGO","BK","NVD3.UK","ALB","NVD2.UK","NVDS","NVDU","INTU","NEM","CDE","NVDY","FERG","AEVA","JXN","REGN","O","RTO.UK","NBP","GL","GNPX","UAA","ACRS","OS","MCHP","GILD","APGE","BALL","ALMS","HL","NVDX","HGT.UK","IFF","CRNX","VST","ACN","NTRS","NVIW.SI","STT","VRTX","AU","VERX","AIG","ZETA"],"gpt_icon":1},{"id":"2601989775","title":"Novabridge Biosciences Shares Climb 6.9% Premarket After Cancer Drug Shows Promise in Early Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601989775","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601989775?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:18","pubTimestamp":1767705534,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nFWN3Y61AU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2601089739","title":"BUZZ-NovaBridge rises as cancer drug shows promise in early trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2601089739","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601089739?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:59","pubTimestamp":1767704397,"startTime":"0","endTime":"0","summary":"BUZZ-NovaBridge rises as cancer drug shows promise in early trial** Shares of drug developer NovaBridge NBP.O rise 6.41% to $4.65 premarket** Co says its experimental cancer drug, givastomig, showed promising results when used with standard chemotherapy and immunotherapy in patients with advanced gastric cancer** Study of 54 patients showed 77% and 73% response rates at two doses, says co** NBP says lower dose delayed cancer progression for nearly 17 months; higher dose data pending ** Co plans global trial comparing drug to standard treatments early this year - NBP** As of last close, stock up ~10% over the past year    ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nL4N3Y70SV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NBP"],"gpt_icon":0},{"id":"2601894584","title":"NovaBridge Biosciences Reports Positive Phase 1b Results for Givastomig in Metastatic Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601894584","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601894584?lang=en_us&edition=fundamental","pubTime":"2026-01-06 20:02","pubTimestamp":1767700930,"startTime":"0","endTime":"0","summary":"NovaBridge Biosciences announced updated results from a Phase 1b combination study of givastomig, a Claudin 18.2  x 4-1BB bispecific antibody, in combination with nivolumab and chemotherapy  for patients with HER2-negative, first-line metastatic gastric cancer. The company reported that the most common givastomig-related treatment-related adverse events  were nausea, vomiting, and fatigue, with Grade 3 incidence at or below 11%. Immune-related gastritis was observed in 33% of patients in both dosing cohorts, with higher rates of Grade 3 gastritis at the 12 mg/kg dose compared to the 8 mg/kg dose. No Grade 5 TRAEs were reported. NovaBridge is preparing to initiate enrollment in a global, randomized Phase 2 study in the first quarter of 2026. Detailed Phase 1b dose expansion data are expected to be presented at a medical conference later in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL241RWg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","LU2210150020.SGD","SG9999014021.USD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210149790.SGD","NBP","LU2095319765.USD","NDAQ","BK4139","SG9999014013.SGD","SG9999014039.USD","IE00B64PRP62.GBP","BK4112","BK4585","IE00BGHQF748.EUR","IE00B3QW5Z07.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}